ACCELERATION OF BONE-MARROW RECOVERY BY PRE-TREATMENT WITH CYCLOPHOSPHAMIDE IN PATIENTS RECEIVING HIGH-DOSE MELPHALAN
β Scribed by Hedley, D.W; Millar, J.L; Mcelwain, T.J; Gordon, M.Y
- Book ID
- 122361688
- Publisher
- The Lancet
- Year
- 1978
- Tongue
- English
- Weight
- 388 KB
- Volume
- 312
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We describe the clinical course of a 16 year old girl with aplastic anemia who was treated by syngeneic bone marrow transplantation. Engraftment was not obtained by simple infusion of bone marrow without immunosuppression. The patient received a high-dose cyclophosphamide and thoracoabdominal irradi
## BACKGROUND. High-dose melphalan (HDM) is now a standard treatment for multiple myeloma (MM). Stem cell transplants are fast evolving as an alternative to bone marrow transplants because they are less traumatic and easier to perform. A study was undertaken to test if whole blood harvested after